Valneva预计2024年收入达到1.696亿欧元（同比增长10%），产品销售额达到1.633亿欧元（同比增长13%）；现金及现金等价物为1.683亿欧元

财报速递

02-18

Valneva公司2024年的销售收入实现了13%的增长（相较于2023年），总收入实现了10%的增长（相较于2023年）。年末强劲的现金头寸为1.683亿欧元。2024年在临床和监管方面取得了显著进展，预计2025年将有多项数据发布、产品批准和标签扩展。2025年的展望反映了稳健的收入增长和积极的商业现金流，以支持战略性的研发投资，同时降低运营现金消耗。

以上内容来自Benzinga Earnings专栏，原文如下：

Met 2024 growth targets for sales revenue (+13% vs 2023) and total revenues (+10% vs 2023)
Strong year-end cash position of €168.3 million
Substantial clinical and regulatory progress in 2024, leading to multiple anticipated data readouts, product approvals and label extensions in 2025
2025 outlook reflects solid revenue growth and positive commercial cash flows to support strategic R&D investments with lower operating cash burn

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1161815401"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1161815401\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1161815401?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-02-18 14:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161815401","market":"us","top_or_hot":-1,"title":"Valneva预计2024年收入达到1.696亿欧元（同比增长10%），产品销售额达到1.633亿欧元（同比增长13%）；现金及现金等价物为1.683亿欧元","media":"财报速递","content":"Valneva公司2024年的销售收入实现了13%的增长（相较于2023年），总收入实现了10%的增长（相较于2023年）。年末强劲的现金头寸为1.683亿欧元。2024年在临床和监管方面取得了显著进展，预计2025年将有多项数据发布、产品批准和标签扩展。2025年的展望反映了稳健的收入增长和积极的商业现金流，以支持战略性的研发投资，同时降低运营现金消耗。<br><br>以上内容来自Benzinga Earnings专栏，原文如下：<br><html><body><ul><li>Met 2024 growth targets for sales revenue (+13% vs 2023) and total revenues (+10% vs 2023)</li><li>Strong year-end cash position of €168.3 million</li><li>Substantial clinical and regulatory progress in 2024, leading to multiple anticipated data readouts, product approvals and label extensions in 2025</li><li>2025 outlook reflects solid revenue growth and positive commercial cash flows to support strategic R&amp;D investments with lower operating cash burn</li></ul></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Valneva预计2024年收入达到1.696亿欧元（同比增长10%），产品销售额达到1.633亿欧元（同比增长13%）；现金及现金等价物为1.683亿欧元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nValneva预计2024年收入达到1.696亿欧元（同比增长10%），产品销售额达到1.633亿欧元（同比增长13%）；现金及现金等价物为1.683亿欧元\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1048278264\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">财报速递 </p>\n<p class=\"h-time\">2025-02-18 14:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\nValneva公司2024年的销售收入实现了13%的增长（相较于2023年），总收入实现了10%的增长（相较于2023年）。年末强劲的现金头寸为1.683亿欧元。2024年在临床和监管方面取得了显著进展，预计2025年将有多项数据发布、产品批准和标签扩展。2025年的展望反映了稳健的收入增长和积极的商业现金流，以支持战略性的研发投资，同时降低运营现金消耗。<br><br>以上内容来自Benzinga Earnings专栏，原文如下：<br><html><body><ul><li>Met 2024 growth targets for sales revenue (+13% vs 2023) and total revenues (+10% vs 2023)</li><li>Strong year-end cash position of €168.3 million</li><li>Substantial clinical and regulatory progress in 2024, leading to multiple anticipated data readouts, product approvals and label extensions in 2025</li><li>2025 outlook reflects solid revenue growth and positive commercial cash flows to support strategic R&amp;D investments with lower operating cash burn</li></ul></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VALN","symbol_name":"Valneva SE","start_time":0,"source_url":"","article_id":"1161815401","we_media_id":"1048278264","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161815401","pubTimestamp":1739861659,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"财报速递","introduction":"每日财报追踪","home_visible":1,"id":"1048278264","head_image":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738"},"summary":"Valneva公司2024年的销售收入实现了13%的增长，总收入实现了10%的增长。年末强劲的现金头寸为1.683亿欧元。2024年在临床和监管方面取得了显著进展，预计2025年将有多项数据发布、产品批准和标签扩展。2025年的展望反映了稳健的收入增长和积极的商业现金流，以支持战略性的研发投资，同时降低运营现金消耗。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"VALN":"Valneva SE"},"translate_title":"Valneva expects 2024 revenue to reach 169.6 million euros (up 10% year-on-year) and product sales to reach 163.3 million euros (up 13% year-on-year); Cash and cash equivalents of € 168. 3 million","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VALN":0.9},"content_text":"Valneva公司2024年的销售收入实现了13%的增长（相较于2023年），总收入实现了10%的增长（相较于2023年）。年末强劲的现金头寸为1.683亿欧元。2024年在临床和监管方面取得了显著进展，预计2025年将有多项数据发布、产品批准和标签扩展。2025年的展望反映了稳健的收入增长和积极的商业现金流，以支持战略性的研发投资，同时降低运营现金消耗。以上内容来自Benzinga Earnings专栏，原文如下：Met 2024 growth targets for sales revenue (+13% vs 2023) and total revenues (+10% vs 2023)Strong year-end cash position of €168.3 millionSubstantial clinical and regulatory progress in 2024, leading to multiple anticipated data readouts, product approvals and label extensions in 20252025 outlook reflects solid revenue growth and positive commercial cash flows to support strategic R&D investments with lower operating cash burn","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0}}}